Home › Funds › Boxer Capital Management, LLC › IRD

Boxer Capital Management, LLC position in IRD

OPUS GENETICS INC · Health Care

Boxer Capital Management, LLC reported holding 4,533,660 shares of IRD (OPUS GENETICS INC) in its Q3 2026 13F filing — a position valued at US$21.9M, representing 1.91% of its reported portfolio and ranking #16 among its reported holdings. Boxer Capital Management, LLC has disclosed IRD holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)4.53M sh
Reported value held$21.94M
Portfolio Weight1.91%
First reportedQ1 2026
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Boxer Capital Management, LLC's IRD position evolved

Boxer Capital Management, LLC first disclosed a stake in IRD in Q1 2026 at 2,250,000 shares (US$10.2M). The position peaked in Q3 2026 at 4,533,660 shares, worth US$21.9M. Across 3 filings, Boxer Capital Management, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,533,660 shares valued at US$21.9M — an increase of 1,718,660 shares quarter over quarter.. Notable position changes include a 25% increase in Q2 2026 (shares rose 18% over the following quarter), a 61% increase in Q3 2026 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 2.25M $10.24M New
Q2 2026 2.81M $11.57M Add
Q3 2026 4.53M $21.94M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IRD and 13F data

IRD (OPUS GENETICS INC) is a Health Care company. 68 other funds we track also report a position in IRD — the largest reported positions include BIOS Capital Management, LP (US$17.83B), PERCEPTIVE ADVISORS LLC (US$43.6M), Caligan Partners LP (US$28.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IRD

All IRD fund holders →

FAQ

How long has Boxer Capital Management, LLC held IRD?

Boxer Capital Management, LLC has disclosed IRD holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Boxer Capital Management, LLC's current position in IRD?

As of Q3 2026, Boxer Capital Management, LLC holds 4.53M shares of IRD (OPUS GENETICS INC), valued at $21.94M, representing 1.91% of its reported portfolio and ranking #16.

Has Boxer Capital Management, LLC been buying or selling IRD?

In the latest 13F filing (Q3 2026), Boxer Capital Management, LLC increased its position in IRD. The position peaked in Q3 2026 at 4.53M shares.

Which other funds hold IRD?

Other major institutional holders of IRD include BIOS Capital Management, LP, PERCEPTIVE ADVISORS LLC, Caligan Partners LP, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.